Cardiac Troponin I and T Are Associated with Left Ventricular Function and Structure: Data from the Akershus Cardiac Examination 1950 Study. (11th February 2020)

• Record Type: Journal Article
• Authors: Lyngbakken, Magnus Nakrem; Aagaard, Erika Nerdrum; Kvisvik, Brede; Berge, Trygve; Pervez, Mohammad Osman; Brynildsen, Jon; Tveit, Arnljot; Steine, Kjetil; Røsjø, Helge; Omland, Torbjørn
• Is Part Of: Clinical chemistry. Volume 66:Number 4(2020)
• Page Start: 567
• Page End: 578
• Publication Date: 2020-02-11
• Subjects: Cardiac troponins -- Echocardiography -- Cardiovascular disease prediction -- Community evaluation; Clinical chemistry -- Periodicals; Pharmaceutical chemistry -- Periodicals; Biochemistry -- Periodicals; Biochimie -- Périodiques; Diagnostics biologiques -- Périodiques; Biochemistry; Clinical chemistry; Pharmaceutical chemistry; Biochemistry; Laboratory Techniques and Procedures; Klinische chemie; Periodicals; 616.075605
• DOI: 10.1093/clinchem/hvaa023
• Languages: English
• ISSNs: 0009-9147

Abstract

Abstract: Background: Concentrations of cardiac troponin I (cTnI) and T (cTnT) are associated with clinical cardiac outcomes, but do not correlate closely in subjects recruited from the general population. Accordingly, we hypothesized that cTnI and cTnT concentrations would be influenced by different cardiovascular (CV) and non-CV risk factors and reflect different CV phenotypes. Methods: We measured cTnI and cTnT with last generation assays in 1236 women and 1157 men with no known CV disease participating in the prospective observational Akershus Cardiac Examination 1950 Study. All study participants underwent extensive CV phenotyping at baseline, including detailed echocardiography. Results: Concentrations of cTnI were measurable in 60.3% and cTnT in 72.5% of study participants ( P < 0.001), and correlated moderately ( r = 0.53; P < 0.001). cTnI was more strongly associated with male sex ( P = 0.018), higher education ( P < 0.001), history of hypertension ( P < 0.001), and age ( P < 0.001), whereas cTnT was more strongly associated with eGFR ( P = 0.015). Both cTnI and cTnT were inversely associated with global longitudinal strain and positively associated with LV mass index (LVMI) in analyses adjusted for CV risk factors. The association between cTnI and LVMI was stronger than the association between cTnT and LVMI ( P = 0.035). Concentrations of cTnI improved diagnostic accuracy for LV hypertrophy when added to established CV risk factors, but concentrations of cTnT did not improve these models further. Conclusions: In a large community-based cohort examined with extensive echocardiography, concentrations of cTnI and cTnT are associated with subclinical LV hypertrophy and dysfunction. Concentrations of cTnI appear superior to cTnT in predicting subclinical LV hypertrophy.